Alan Tyndall

22.2k total citations · 1 hit paper
158 papers, 7.2k citations indexed

About

Alan Tyndall is a scholar working on Pathology and Forensic Medicine, Hematology and Rheumatology. According to data from OpenAlex, Alan Tyndall has authored 158 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Pathology and Forensic Medicine, 42 papers in Hematology and 35 papers in Rheumatology. Recurrent topics in Alan Tyndall's work include Systemic Sclerosis and Related Diseases (72 papers), Hematopoietic Stem Cell Transplantation (31 papers) and Mesenchymal stem cell research (30 papers). Alan Tyndall is often cited by papers focused on Systemic Sclerosis and Related Diseases (72 papers), Hematopoietic Stem Cell Transplantation (31 papers) and Mesenchymal stem cell research (30 papers). Alan Tyndall collaborates with scholars based in Switzerland, Italy and United Kingdom. Alan Tyndall's co-authors include Aloïs Gratwohl, Marco Matucci‐Cerinic, Ulrich A. Walker, Chiara Bocelli‐Tyndall, Jacob M. van Laar, Dominique Farge, Thomas Daikeler, Ulf Müller‐Ladner, Christopher P. Denton and Otylia Kowal‐Bielecka and has published in prestigious journals such as The Lancet, Nature Medicine and Blood.

In The Last Decade

Alan Tyndall

153 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

2007 628 citations Ulrich A. Walker, Alan Tyndall et al. Annals of the Rheumatic Diseases profile →

Peers

Countries citing papers authored by Alan Tyndall

Since Specialization

Citations

This map shows the geographic impact of Alan Tyndall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Tyndall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Tyndall more than expected).

Fields of papers citing papers by Alan Tyndall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Tyndall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Tyndall. The network helps show where Alan Tyndall may publish in the future.

Co-authorship network of co-authors of Alan Tyndall

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Tyndall. A scholar is included among the top collaborators of Alan Tyndall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Tyndall. Alan Tyndall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mesenchymal stromal cells and rheumatic disorders 2015 ·Immunology Letters ·Alan Tyndall	11
2	OC-014 Clinical and Endoscopic Improvement following Hemopoietic Stem Cell Transplantation vs Mobilisatiion alone in Crohn’S Disease 2013 ·Gut ·C J Hawkey, Matthieu Allez, Sandro Ardizzone, (unknown), (unknown), Silvio Danese, (unknown), (unknown), James O. Lindsay, Aaron D. Norman, Francesco Onida, (unknown), (unknown), Miquel Rovira, Noah A. Russell, Jack Satsangi, Simon Travis, Alan Tyndall, Séverine Vermeire	1
3	The Survey on Cellular and Engineered Tissue Therapies in Europe in 2011 2013 ·Tissue Engineering Part A ·Iván Martín, Helen Baldomero, Chiara Bocelli‐Tyndall, Maximilian Y. Emmert, Simon P. Hoerstrup, (unknown), Jakob Passweg, Alan Tyndall	65
4	The Survey on Cellular and Engineered Tissue Therapies in Europe in 2010 2012 ·Tissue Engineering Part A ·Iván Martín, Helen Baldomero, Chiara Bocelli‐Tyndall, Jakob Passweg, Daniël B.F. Saris, Alan Tyndall	29
5	Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database 2012 ·Lara D. Veeken ·(unknown), Alan Tyndall, Jonathan Kay, Klaus Søndergaard, Patrícia Carreira, (unknown), Kurt W. Deuschle, Chris T. Derk, (unknown), Ulrich A. Walker	18
6	The Survey on Cellular and Engineered Tissue Therapies in Europe in 2009 2011 ·Tissue Engineering Part A ·Iván Martín, Helen Baldomero, Chiara Bocelli‐Tyndall, Ineke Slaper‐Cortenbach, Jakob Passweg, Alan Tyndall	26
7	Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor 2010 ·Haematologica ·Alicia Rovó, Thomas Daikeler, Jörg Halter, Dominik Heim, Dimitrios A. Tsakiris, M. Stern, Tuomas Waltimo, Jan–Dirk Studt, Alan Tyndall, Aloïs Gratwohl, André Tichelli	22
8	Characteristics of Joint Involvement and Relationships with Systemic Inflammation in Systemic Sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) Database 2010 ·The Journal of Rheumatology ·Jérôme Avouac, Ulrich A. Walker, Alan Tyndall, André Kahan, Marco Matucci‐Cerinic, Yannick Allanore	144
9	Multisegmental spondylitis due to Tropheryma whipplei: Case report 2009 ·Orphanet Journal of Rare Diseases ·David Spoerl, (unknown), Julian C. Cooper, Thomas Vogt, Alan Tyndall, Ulrich A. Walker	15
10	Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks 2009 ·Bone Marrow Transplantation ·Alan Tyndall, Antonio Uccelli	82
11	Why do we need noncommercial, investigator-initiated clinical trials? 2008 ·Nature Clinical Practice Rheumatology ·Alan Tyndall	10
12	Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database 2008 ·Annals of the Rheumatic Diseases ·Ulrich A. Walker, Alan Tyndall, L. Czirják, Christopher P. Denton, Dominique Farge, Otylia Kowal‐Bielecka, Ulf Müller‐Ladner, Marco Matucci‐Cerinic	58
13	Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database breakdown → 2007 ·Annals of the Rheumatic Diseases ·Ulrich A. Walker, Alan Tyndall, L. Czirják, Christopher P. Denton, Dominique Farge, Otylia Kowal‐Bielecka, Ulf Müller‐Ladner, Chiara Bocelli‐Tyndall, Marco Matucci‐Cerinic	628
14	Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis 2007 ·Annals of the Rheumatic Diseases ·Jérôme Larghero, Dominique Farge, Alessandra Braccini, Séverine Lecourt, Arnaud Scherberich, Eléna Foïs, Franck Verrecchia, (unknown), Éliane Gluckman, Alan Tyndall, Chiara Bocelli‐Tyndall	94
15	Adult stem cells in the treatment of autoimmune diseases 2006 ·Lara D. Veeken ·Jacob M. van Laar, Alan Tyndall	75
16	Progress in hematopoietic stem cell transplantation for autoimmune diseases 2005 ·Expert Review of Clinical Immunology ·Alan Tyndall, Dominique Farge	1
17	Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis 2004 ·Bone Marrow Transplantation ·Riccardo Saccardi, Alan Tyndall, Gerry Coghlan, Christopher P. Denton, Gilles Edan, Michele Emdin, Dominique Farge, Αthanasios Fassas, Jürgen Finke, Daniel E. Furst, M. Lassus, Gianluigi Mancardi, Irene Miniati, Enrico Mini, F. Pagliai, Jakob Passweg, Alberto Moggi Pignone, Jacob M. van Laar, Chiara Bocelli‐Tyndall, Marco Matucci‐Cerinic	48
18	Haematopoietic Stem Cell Transplantation (HSCT) for Severe Autoimmune Disease : An Update of Results and Planned Trials 2001 ·Alan Tyndall	3
19	Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation 2000 ·Journal of Neurology ·(unknown), Gıancarlo Comı, Ludwig Kappos, Michel Clanet, George C. Ebers, Αthanasios Fassas, Franz Fazekas, Massimo Filippi, Hans‐Peter Hartung, Bernd Hertenstein, (unknown), Gianvito Martino, Alan Tyndall, F.G.A. van der Meché	59
20	Hemopoietic blood and marrow transplants in the treatment of severe autoimmune disease 1997 ·Current Opinion in Hematology ·Alan Tyndall, Aloïs Gratwohl	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact